CA2123647A1

Bioabsorbable copolymer and coating composition containing same

Abstract

A bioabsorbable copolymer is obtained from the polymerization of a major amount of epsilon-caprolactone and a minor amount of at least one other copolymerizable monomer in the presence of a polyhydric alcohol initiator. The copolymer is useful, inter alia, as a coating for a surgical suture.

CA2123647A1, drawing sheet 1
Sheet 1 of 5

Term

Term ended

Projected expiry passed 16 May 2014, 12.4 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

15 claims: 4 independent, 11 dependent

  1. 1
    2} tup:embodiments of the invention in which an exclusive property OK PRIVILEGE is claimed are defined AS FOLLOWS: 1. A bioabsorbable copolymer obtained by polymerizing 5 a major amount of epsilon-caprolactone and a minor amount of at least one other copolymerizable monomer in the presence of polyhydric alcohol as initiator.
  2. 2
    The copolymer of Claim 1 wherein the other 10 copolymerizable monomer is selected from the group consisting of glycolide, lactide, p-dioxanone and trimethylene carbonate.
  3. 3
    The copolymer of Claim 1 wherein the polyhydric alcohol initiator is selected from the group consisting of 15 glycerol, trimethylolpropane, 1,2,4-butanetriol, 1,2,6hexanetriol, triethanolamine, triisopropanolamine, erythritol, threitol, pentaerythritol, ribitol, arabinitol, xylitol, N,N,N',N 1 -tetrakis(2-hydroxy-ethyl)ethylenediamine, N,N,N',N'tetrakis(2-hydroxypropyl) ethylenediamine, dipentaerythritol, 20 allitol, dulcitol, glucitol, altritol, iditol, sorbitol, mannitol and inositol.
  4. 4
    The copolymer of Claim 1 containing from about 70 to about 98 weight percent epsilon-caprolactone-derived units, 25 the balance of the copolymer being derived from the other copolymerizable monomer(s).
  5. 5
    The copolymer of Claim 1 possessing an inherent viscosity of from about 0.10 to about 0.60 dl/g when measured in 30 chloroform at a concentration of 0.2500 g/dl at 30“C.
  6. 6
    The copolymer of Claim 1 wherein the polyhydric alcohol is employed in an amount of from about 0.5 to about 5 weight percent of the total monomer mixture. 2123847
  7. 7
    A medical device fabricated in whole or in part ft oui a bioabsorbable copolymer obtained by polymerizing a major amount of epsilon-caprolactone and a minor amount of at least one other copolymerizable monomer in the presence of polyhydric 5 alcohol as initiator.
  8. 8
    The medical device of Claim 7 wherein the other copolymerizable monomer is selected from the group consisting of qlycolide, lactide, p-dioxanone and trimethylene carbonate.
  9. 9
    The medical device of Claim 7 wherein the polyhydric alcohol initiator is selected from the group consisting of glycerol, trimethylolpropane, 1,2,4-butanetriol, 1,λ ,6-hexanetriol, triethanolamine, triisopropanolamine, 15 erythritol, threitol, pentaerythritol, ribitol, arabinitol, xylitol, Ν,Ν,Ν',N'-tetrakis(2-hydroxy-ethyl)ethylenediamine, Ν,Ν,Ν',N'-tetrakis(2-hydroxypropyl) ethylenediamine, dipentaerythritol, allitol, dulcitol, glucitol, altritol, iditol, sorbitol, mannitol and inositol.
  10. 10
    The medical device of Claim 7 wherein the copolymer contains from about 70 to about 98 weight percent epsilon-caprolactone-derived units, the balance of the copolymer being derived from the other copolymerizable monomer(s).
  11. 11
    The medical device of Claim 7 wherein the copolymer possesses an inherent viscosity from about 0.10 to about 0.60 dl/g when measured in chloroform at a concentration of 0.2500 g/dl at 30’C.
  12. 12
    The medical device of Claim 7 wherein the polyhydric alcohol initiator is employed in an amount of from about 0.5 to about 5 weight percent of the total monomer mixture. 35
  13. 14
    Use of the composition of any one of claims 1, 2, 3,4, 5 or 6 for a medical device.
  14. 15
    Use of the composition of any one of claims 1, 2, 3, 4, 5 or 6 for a medical device wherein the medical device is a suture coated with a copolymer.